UniProt ID | KCIP2_HUMAN | |
---|---|---|
UniProt AC | Q9NS61 | |
Protein Name | Kv channel-interacting protein 2 | |
Gene Name | KCNIP2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 270 | |
Subcellular Localization |
Isoform 1: Cell membrane Lipid-anchor . Detected on lipid rafts (By similarity). Isoform 2: Cell membrane Lipid-anchor . Isoform 6: Cell membrane Lipid-anchor . |
|
Protein Description | Regulatory subunit of Kv4/D (Shal)-type voltage-gated rapidly inactivating A-type potassium channels. Modulates channel density, inactivation kinetics and rate of recovery from inactivation in a calcium-dependent and isoform-specific manner. In vitro, modulates KCND2/Kv4.2 and KCND3/Kv4.3 currents. Involved in KCND2 and KCND3 trafficking to the cell surface. May be required for the expression of I(To) currents in the heart (By similarity).. | |
Protein Sequence | MRGQGRKESLSDSRDLDGSYDQLTGHPPGPTKKALKQRFLKLLPCCGPQALPSVSETLAAPASLRPHRPRLLDPDSVDDEFELSTVCHRPEGLEQLQEQTKFTRKELQVLYRGFKNECPSGIVNEENFKQIYSQFFPQGDSSTYATFLFNAFDTNHDGSVSFEDFVAGLSVILRGTVDDRLNWAFNLYDLNKDGCITKEEMLDIMKSIYDMMGKYTYPALREEAPREHVESFFQKMDRNKDGVVTIEEFIESCQKDENIMRSMQLFDNVI | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
9 | Phosphorylation | RGQGRKESLSDSRDL CCCCCCCCCCCCCCC | 35.89 | - | |
19 | Phosphorylation | DSRDLDGSYDQLTGH CCCCCCCCHHHHCCC | 25.79 | 25307156 | |
20 (in isoform 9) | Phosphorylation | - | 17.15 | - | |
20 (in isoform 7) | Phosphorylation | - | 17.15 | - | |
20 (in isoform 5) | Phosphorylation | - | 17.15 | - | |
20 (in isoform 3) | Phosphorylation | - | 17.15 | - | |
20 | Phosphorylation | SRDLDGSYDQLTGHP CCCCCCCHHHHCCCC | 17.15 | 25332170 | |
24 | Phosphorylation | DGSYDQLTGHPPGPT CCCHHHHCCCCCCCC | 28.01 | - | |
31 | Phosphorylation | TGHPPGPTKKALKQR CCCCCCCCHHHHHHH | 51.60 | - | |
45 | S-palmitoylation | RFLKLLPCCGPQALP HHHHHHCCCCCCCCC | 4.17 | - | |
46 | S-palmitoylation | FLKLLPCCGPQALPS HHHHHCCCCCCCCCC | 9.34 | - | |
55 (in isoform 6) | Phosphorylation | - | 29.24 | 25159151 | |
103 | Phosphorylation | LQEQTKFTRKELQVL HHHHHCCCHHHHHHH | 42.24 | 18220336 | |
111 | Phosphorylation | RKELQVLYRGFKNEC HHHHHHHHHHHCCCC | 15.16 | 18220336 | |
207 | Phosphorylation | EMLDIMKSIYDMMGK HHHHHHHHHHHHHHH | 14.70 | 24719451 | |
209 | Phosphorylation | LDIMKSIYDMMGKYT HHHHHHHHHHHHHCC | 12.60 | - | |
216 | Phosphorylation | YDMMGKYTYPALREE HHHHHHCCHHHHHHH | 26.89 | 24719451 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of KCIP2_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of KCIP2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of KCIP2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
KCND3_HUMAN | KCND3 | physical | 12928444 | |
KCND2_HUMAN | KCND2 | physical | 20498229 | |
KCNE4_HUMAN | KCNE4 | physical | 20498229 | |
KCND2_HUMAN | KCND2 | physical | 10676964 | |
KCIP2_HUMAN | KCNIP2 | physical | 15358149 | |
KCIP1_HUMAN | KCNIP1 | physical | 26186194 | |
AN13A_HUMAN | ANKRD13A | physical | 26186194 | |
S10A7_HUMAN | S100A7 | physical | 26186194 | |
KCIP1_HUMAN | KCNIP1 | physical | 28514442 | |
S10A7_HUMAN | S100A7 | physical | 28514442 | |
AN13A_HUMAN | ANKRD13A | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-103 AND TYR-111, ANDMASS SPECTROMETRY. |